Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma

• Published in: Hypertension (Dallas, Tex. 1979) Vol. 75; no. 4; pp. 1034 - 1044
• Main Authors: De Sousa, Kelly, Boulkroun, Sheerazed, Baron, Stéphanie, Nanba, Kazutaka, Wack, Maxime, Rainey, William E., Rocha, Angélique, Giscos-Douriez, Isabelle, Meatchi, Tchao, Amar, Laurence, Travers, Simon, Fernandes-Rosa, Fabio L., Zennaro, Maria-Christina
• Format: Journal Article
• Language: English
• Published: United States American Heart Association, Inc 01.04.2020; American Heart Association; Lippincott, Williams & Wilkins
• Subjects: Adrenal Cortex Neoplasms - genetics; Adrenal Cortex Neoplasms - metabolism; Adrenal Cortex Neoplasms - pathology; Adrenal Glands - metabolism; Adrenal Glands - pathology; Adrenocortical Adenoma - genetics; Adrenocortical Adenoma - metabolism; Adrenocortical Adenoma - pathology; Adult; Aged; Aldosterone - metabolism; Cardiology and cardiovascular system; Cytochrome P-450 CYP11B2 - genetics; Cytochrome P-450 CYP11B2 - metabolism; Endocrinology and metabolism; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels - genetics; G Protein-Coupled Inwardly-Rectifying Potassium Channels - metabolism; Genetics; Human health and pathology; Humans; Hyperaldosteronism - genetics; Hyperaldosteronism - metabolism; Hyperaldosteronism - pathology; Immunohistochemistry; Life Sciences; Male; Middle Aged; Mutation; Original; Steroid 11-beta-Hydroxylase - genetics; Steroid 11-beta-Hydroxylase - metabolism; arterial hypertension; mutation; adrenal cortex; mineralocorticoids; aldosterone; primary aldosteronism
• ISSN: 0194-911X; 1524-4563; 1524-4563
• DOI: 10.1161/HYPERTENSIONAHA.119.14177

Aldosterone-producing adenoma (APA) cause primary aldosteronism—the most frequent form of secondary hypertension. Somatic mutations in genes coding for ion channels and ATPases are found in APA and in aldosterone-producing cell clusters. We investigated the genetic, cellular, and molecular heterogeneity of different aldosterone-producing structures in adrenals with APA, to get insight into the mechanisms driving their development and to investigate their clinical and biochemical correlates. Genetic analysis of APA, aldosterone-producing cell clusters, and secondary nodules was performed in adrenal tissues from 49 patients by next-generation sequencing following CYP11B2 immunohistochemistry. Results were correlated with clinical and biochemical characteristics of patients, steroid profiles, and histological features of the tumor and adjacent adrenal cortex. Somatic mutations were identified in 93.75% of APAs. Adenoma carrying KCNJ5 mutations had more clear cells and cells expressing CYP11B1, and fewer cells expressing CYP11B2 or activated β-catenin, compared with other mutational groups. 18-hydroxycortisol and 18-oxocortisol were higher in patients carrying KCNJ5 mutations and correlated with histological features of adenoma; however, mutational status could not be predicted using steroid profiling. Heterogeneous CYP11B2 expression in KCNJ5-mutated adenoma was not associated with genetic heterogeneity. Different mutations were identified in secondary nodules expressing aldosterone synthase and in independent aldosterone-producing cell clusters from adrenals with adenoma; known KCNJ5 mutations were identified in 5 aldosterone-producing cell clusters. Genetic heterogeneity in different aldosterone-producing structures in the same adrenal suggests complex mechanisms underlying APA development.